Has Angela Jones received payments from drug or device companies?

Yes. Drug and device makers reported $6,280 in general payments to Angela Jones across 294 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angela Jones did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angela Jones come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angela Jones

Psychiatric/Mental Health · Clinton, LANPI 1194023762

Payments from drug & device makers

$6,280in general payments, 2019–2025

Across 294 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
Corium, LLC$951
Axsome Therapeutics, Inc.$673
Alkermes, Inc.$298
E.r. Squibb & Sons, L.L.C.$201
plus $2K from 15 others

What the payments were for

Food & beverage$6,21799%
Education$631%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	90	$1,370
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	56	$1,131
Corium, LLC	53	$951
Axsome Therapeutics, Inc.	17	$673
Alkermes, Inc.	11	$298
E.r. Squibb & Sons, L.L.C.	5	$201
Takeda Pharmaceuticals U.S.A., Inc.	10	$198
Vanda Pharmaceuticals Inc.	3	$184
Collegium Pharmaceutical, Inc.	6	$179
Ironshore Pharmaceuticals Inc.	8	$178
Otsuka America Pharmaceutical, Inc.	8	$172
Boston Scientific	2	$157
Lilly USA, LLC	2	$152
Supernus Pharmaceuticals, Inc.	7	$117
Lundbeck LLC	5	$101
Johnson & Johnson	4	$79
Teva Pharmaceuticals USA, Inc.	2	$42
Neurocrine Biosciences, Inc.	1	$28
Sunovion Pharmaceuticals Inc.	2	$28
Dexcom, Inc.	1	$24
Tris Pharma Inc	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auvelity$364
CAPLYTA$348
VRAYLAR$233
Azstarys$229
ZEPBOUND$144
Fanapt$125
SEISMIQ Prime Catheter_PI$123
JORNAY PM$105
COBENFY$100

How this compares

$6,280 in reported general payments places this provider in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CaplytaLumateperone Tosylate	19	$33,578
PerserisRisperidone	11	$29,977
Aripiprazole	100	$5,567
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	12	$2,016
Chlorpromazine Hcl	14	$1,811
Duloxetine Hcl	109	$1,615
Clozapine	23	$1,573
Paliperidone ErPaliperidone	14	$1,490
Buspirone Hcl	83	$1,316
Trazodone Hcl	119	$1,204
Divalproex Sodium ErDivalproex Sodium	42	$1,105
Oxcarbazepine	22	$912
Quetiapine Fumarate	69	$719
Risperidone	87	$689
Doxepin Hcl	15	$641

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$1,131	$33,57819 claims
Lilly USA, LLCOlanzapine	$152	$50041 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Clinton

Amy LacoutureBaton Rouge$663K
Amanda EymardHouma$617K
Amber LittlefieldBroussard$225K
Timothy PellegrinHouma$210K
Melissa GuilbeauLafayette$122K
Kimberly ForcinelShreveport$92K
Sattaria DilksLake Charles$57K
Joe TaylorHammond$38K
Lecy AlbaradoScott$34K
Michelle DyerLake Charles$33K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →